About

I am a Senior Lecturer within the Public Health team at the School of Health and Social Care at the University of Derby.

My career spans academia, industry, and consulting, with prior roles at universities including Teesside, Salford, Wolverhampton, Hertfordshire, and the University of Indonesia, as well as roles in government affairs, market access, and strategy consulting for healthcare and business consulting companies.

Teaching responsibilities

I develop and deliver postgraduate modules in Epidemiology, Statistics, Research Methodology and Health Economics, both for classroom and online deliveries through UDOL. I am also involved in the delivery of other relevant modules within the College.

Research interests

My research focuses on global public health epidemiology, health economics, health systems, and access to pharmaceutical products.  

Qualifications

• First Degree/BSc in Public Health – University of Indonesia
• Post Graduate Certificate in Economics - University of York
• MSc in Health Economics - University of York
• Post Graduate Certificate in Higher Education Research and Practice - University of Salford

Recent conferences

2025: Invited to speak in a number of conferences hold by Swami Rama Himalayan University (India), Apeejay School of Management(India), University of Jember (Indonesia), and Nahdlatul Ulama Sunan Giri University (Indonesia)

Experience in industry

I spent almost 4 years with one of the largest global Pharmaceutical Companies in the area of Government Affairs, Market Access and Communications for their Indonesian operations. Earlier in my career, I also worked for a global consulting firm specialising in the area of Strategy and Planning.

International experience

I have been involved in many teaching, research and consulting projects with various partners in Indonesia.  I have been asked to deliver visiting lectures for the University of North Sumatera, University of Indonesia, Indonesia Veteran University, Hasanuddin University, Diponegoro University, Aisyiyah University, and several others.

While working for one of the largest global pharmaceutical companies, I was involved global and regional issues in pharmaceutical pricing, access, and policies that affect access to medicines to patients.  

I have also worked for a consulting project supporting the Ministry of Health of the Kingdom of Saudi Arabia.

In the media

I have been quoted in global media around the response to COVID-19 for example by the New York Times, Bloomberg, and Reuters. I have also been interviewed by numerous online media including TV appearances.

Recent publications

• Jude, E.B., Saluja, S., Heald, A. et al. (2025) Improving Diabetes and Pre-Diabetes Detection in the UK: Insights From HbA1c Screening in an Acute Hospital’s Emergency Department. Diabetes Therapy. https://doi.org/10.1007/s13300-025-01777-w
• Adeel, T and Widiatmoko, D. (2024). Assessment of Risk Factors Associated with Acute Respiratory Infections (ARIs) Among Children Under 6 Years of Age, Pakistan. The Indonesian Journal of Public Health. 19 (2), pp. 1-12. https://doi.org/10.20473/ijph.v19i2.2024.251-262
• Kasri, R.A., Ahsan, A., Widiatmoko, D. and Hati, S.R.H. (2023). Intention to consume halal pharmaceutical products: evidence from Indonesia. Journal of Islamic Marketing 10 February 2023; 14 (3): 735–756. https://doi.org/10.1108/JIMA-06-2021-0192
• Khan, R. A., Brown, J., & Widiatmoko, D. (2021). Prevalence of influenza vaccination coverage amongst the first and third-generation Asian adults in California, United States of America. Life Res, 4(2), 12
• Widiatmoko, D., Aji, B., & Wijayanti, S. P. M. (2021). Public Health Awareness and Preparedness of Covid-19: Where are We? Insights in Public Health Journal, 1(2), 1-2
• Widiatmoko, D (2020). ‘Covid-19 Drug buyout threatens Developing Nations’. The Jakarta Post, 16 July 2020
• Widiatmoko, D (2020). ‘Robust Health Care is ‘New Normal’ for Indonesia’. The Jakarta Post, 25 June 2020